questionsmedicales.fr
Préparations pharmaceutiques
Substances illicites
Substances illicites : Questions médicales fréquentes
Diagnostic
5
Dépendance aux drogues
Évaluation psychologique
Tests de dépistage
Drogues illicites
Évaluation de la consommation
Drogues
Complications
Drogues illicites
Symptômes
5
Sevrage
Dépendance aux drogues
Effets psychologiques
Drogues illicites
Comportement
Drogues illicites
Prévention
5
Prévention
Éducation à la santé
Politiques publiques
Prévention
Signes d'alerte
Adolescents
Traitements
5
Traitement de la dépendance
Thérapies comportementales
Désintoxication
Drogues illicites
Suivi
Prévention des rechutes
Thérapies de groupe
Soutien social
Complications
5
Complications
Drogues illicites
Transmission de maladies
Drogues injectables
Santé mentale
Drogues illicites
Facteurs de risque
5
Facteurs de risque
Dépendance aux drogues
Âge
Consommation de drogues
Environnement social
Drogues illicites
Antécédents familiaux
Dépendance aux drogues
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Substances illicites : Questions médicales les plus fréquentes",
"headline": "Substances illicites : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Substances illicites : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-05",
"dateModified": "2026-04-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Substances illicites"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Préparations pharmaceutiques",
"url": "https://questionsmedicales.fr/mesh/D004364",
"about": {
"@type": "MedicalCondition",
"name": "Préparations pharmaceutiques",
"code": {
"@type": "MedicalCode",
"code": "D004364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D26"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Crack",
"alternateName": "Crack Cocaine",
"url": "https://questionsmedicales.fr/mesh/D016578",
"about": {
"@type": "MedicalCondition",
"name": "Crack",
"code": {
"@type": "MedicalCode",
"code": "D016578",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D26.878.250"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Substances illicites",
"alternateName": "Illicit Drugs",
"code": {
"@type": "MedicalCode",
"code": "D013287",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kanna Hayashi",
"url": "https://questionsmedicales.fr/author/Kanna%20Hayashi",
"affiliation": {
"@type": "Organization",
"name": "British Columbia Centre on Substance Use, Vancouver, Canada."
}
},
{
"@type": "Person",
"name": "Huiru Dong",
"url": "https://questionsmedicales.fr/author/Huiru%20Dong",
"affiliation": {
"@type": "Organization",
"name": "British Columbia Centre on Substance Use, Vancouver, Canada."
}
},
{
"@type": "Person",
"name": "Andrew Day",
"url": "https://questionsmedicales.fr/author/Andrew%20Day",
"affiliation": {
"@type": "Organization",
"name": "Vancouver Coastal Health, Vancouver, Canada."
}
},
{
"@type": "Person",
"name": "Rachael McKendry",
"url": "https://questionsmedicales.fr/author/Rachael%20McKendry",
"affiliation": {
"@type": "Organization",
"name": "Vancouver Coastal Health, Vancouver, Canada."
}
},
{
"@type": "Person",
"name": "Rolando Barrios",
"url": "https://questionsmedicales.fr/author/Rolando%20Barrios",
"affiliation": {
"@type": "Organization",
"name": "Vancouver Coastal Health, Vancouver, Canada."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Luminescence-based detection and identification of illicit drugs.",
"datePublished": "2023-05-17",
"url": "https://questionsmedicales.fr/article/37144605",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d3cp00524k"
}
},
{
"@type": "ScholarlyArticle",
"name": "The decriminalization of illicit drugs in British Columbia: a national evaluation protocol.",
"datePublished": "2024-10-18",
"url": "https://questionsmedicales.fr/article/39425094",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-024-20336-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Analyzing the geographic influence of financial inclusion on illicit drug use in Nigeria.",
"datePublished": "2024-04-30",
"url": "https://questionsmedicales.fr/article/38876566",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.sste.2024.100655"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence of illicit drug use in young patients with sudden cardiac death.",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37295741",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.hrthm.2023.06.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "A study on the mediating-moderate effect of the types of illicit drugs on mental health in China.",
"datePublished": "2024-09-10",
"url": "https://questionsmedicales.fr/article/39319299",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2024.1431854"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Préparations pharmaceutiques",
"item": "https://questionsmedicales.fr/mesh/D004364"
},
{
"@type": "ListItem",
"position": 3,
"name": "Substances illicites",
"item": "https://questionsmedicales.fr/mesh/D013287"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Substances illicites - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Substances illicites",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Substances illicites",
"description": "Comment diagnostiquer une dépendance aux drogues ?\nQuels tests peuvent détecter les drogues ?\nQuels signes indiquent une intoxication ?\nComment évaluer le niveau de consommation ?\nQuelles sont les complications à rechercher ?",
"url": "https://questionsmedicales.fr/mesh/D013287#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Substances illicites",
"description": "Quels sont les symptômes d'une overdose ?\nComment reconnaître le sevrage ?\nQuels effets psychologiques sont observés ?\nQuels signes physiques sont associés ?\nComment les drogues affectent-elles le comportement ?",
"url": "https://questionsmedicales.fr/mesh/D013287#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Substances illicites",
"description": "Quelles stratégies de prévention existent ?\nComment sensibiliser les jeunes aux dangers ?\nQuel rôle jouent les familles dans la prévention ?\nComment les politiques publiques aident-elles ?\nQuels sont les signes d'alerte chez les adolescents ?",
"url": "https://questionsmedicales.fr/mesh/D013287#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Substances illicites",
"description": "Quels traitements sont disponibles pour la dépendance ?\nComment fonctionne la désintoxication ?\nQuels médicaments sont utilisés pour le sevrage ?\nQuelle est l'importance du suivi post-traitement ?\nComment les thérapies de groupe aident-elles ?",
"url": "https://questionsmedicales.fr/mesh/D013287#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Substances illicites",
"description": "Quelles sont les complications à long terme ?\nComment les drogues affectent-elles la santé physique ?\nQuels risques de transmission de maladies ?\nComment les drogues influencent-elles la santé mentale ?\nQuels impacts sociaux sont observés ?",
"url": "https://questionsmedicales.fr/mesh/D013287#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Substances illicites",
"description": "Quels facteurs augmentent le risque de dépendance ?\nQuel rôle joue l'âge dans la consommation ?\nComment l'environnement social influence-t-il ?\nQuels troubles mentaux sont des facteurs de risque ?\nComment les antécédents familiaux influencent-ils ?",
"url": "https://questionsmedicales.fr/mesh/D013287#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dépendance aux drogues ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des critères cliniques, l'historique d'usage et des évaluations psychologiques."
}
},
{
"@type": "Question",
"name": "Quels tests peuvent détecter les drogues ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests urinaires, sanguins ou capillaires peuvent détecter la présence de drogues."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une intoxication ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent confusion, agitation, hallucinations et troubles de la coordination."
}
},
{
"@type": "Question",
"name": "Comment évaluer le niveau de consommation ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des questionnaires standardisés et des entretiens cliniques."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications à rechercher ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles mentaux, des maladies infectieuses et des problèmes cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une overdose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent respiration lente, perte de conscience, et cyanose des lèvres."
}
},
{
"@type": "Question",
"name": "Comment reconnaître le sevrage ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le sevrage se manifeste par anxiété, tremblements, nausées et insomnie."
}
},
{
"@type": "Question",
"name": "Quels effets psychologiques sont observés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets incluent dépression, anxiété, et troubles de la mémoire."
}
},
{
"@type": "Question",
"name": "Quels signes physiques sont associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes physiques peuvent inclure perte de poids, pupilles dilatées et problèmes cutanés."
}
},
{
"@type": "Question",
"name": "Comment les drogues affectent-elles le comportement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer des changements d'humeur, impulsivité et comportements à risque."
}
},
{
"@type": "Question",
"name": "Quelles stratégies de prévention existent ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les stratégies incluent l'éducation, la sensibilisation et des programmes communautaires."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser les jeunes aux dangers ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des ateliers, des campagnes et des interventions scolaires peuvent sensibiliser les jeunes."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les familles dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les familles peuvent offrir un soutien émotionnel et des informations sur les risques."
}
},
{
"@type": "Question",
"name": "Comment les politiques publiques aident-elles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent réglementer l'accès aux drogues et financer des programmes de prévention."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'alerte chez les adolescents ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des changements de comportement, isolement et baisse des performances scolaires."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la dépendance ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent thérapies comportementales, médicaments et groupes de soutien."
}
},
{
"@type": "Question",
"name": "Comment fonctionne la désintoxication ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La désintoxication consiste à éliminer les drogues du corps sous surveillance médicale."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour le sevrage ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme la méthadone ou la buprénorphine sont utilisés pour le sevrage."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance du suivi post-traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le suivi est crucial pour prévenir les rechutes et soutenir la réhabilitation."
}
},
{
"@type": "Question",
"name": "Comment les thérapies de groupe aident-elles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles offrent un soutien social et partagent des expériences, favorisant la guérison."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications à long terme ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des maladies chroniques, des troubles mentaux et des problèmes sociaux."
}
},
{
"@type": "Question",
"name": "Comment les drogues affectent-elles la santé physique ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent causer des maladies cardiaques, des infections et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Quels risques de transmission de maladies ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'usage de drogues injectables augmente le risque de transmission du VIH et de l'hépatite."
}
},
{
"@type": "Question",
"name": "Comment les drogues influencent-elles la santé mentale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent aggraver des troubles mentaux existants et provoquer de nouveaux problèmes psychologiques."
}
},
{
"@type": "Question",
"name": "Quels impacts sociaux sont observés ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les impacts incluent la stigmatisation, la criminalité et la désintégration familiale."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de dépendance ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hérédité, l'environnement social et les troubles mentaux."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'âge dans la consommation ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les jeunes adultes sont plus susceptibles de consommer des drogues en raison de la recherche de sensations."
}
},
{
"@type": "Question",
"name": "Comment l'environnement social influence-t-il ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un environnement social instable ou exposé à la consommation augmente le risque d'usage."
}
},
{
"@type": "Question",
"name": "Quels troubles mentaux sont des facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les troubles comme la dépression et l'anxiété augmentent le risque de consommation de drogues."
}
},
{
"@type": "Question",
"name": "Comment les antécédents familiaux influencent-ils ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un historique familial de dépendance peut prédisposer les individus à développer des problèmes similaires."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 25/04/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
British Columbia Centre on Substance Use, Vancouver, Canada.
Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.
Publications dans "Substances illicites" :
3 publications dans cette catégorie
Affiliations :
British Columbia Centre on Substance Use, Vancouver, Canada.
School of Population and Public Health, University of British Columbia, Vancouver, Canada.
Publications dans "Substances illicites" :
3 publications dans cette catégorie
Affiliations :
Vancouver Coastal Health, Vancouver, Canada.
Publications dans "Substances illicites" :
3 publications dans cette catégorie
Affiliations :
Vancouver Coastal Health, Vancouver, Canada.
Publications dans "Substances illicites" :
3 publications dans cette catégorie
Affiliations :
Vancouver Coastal Health, Vancouver, Canada.
British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, Canada.
Publications dans "Substances illicites" :
3 publications dans cette catégorie
Affiliations :
British Columbia Centre on Substance Use, Vancouver, Canada.
Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Publications dans "Substances illicites" :
3 publications dans cette catégorie
Affiliations :
British Columbia Centre on Substance Use, Vancouver, Canada.
Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Publications dans "Substances illicites" :
3 publications dans cette catégorie
Affiliations :
College of Science & Engineering, Flinders University, Adelaide 5042, Australia. Electronic address: amy.griffin@flinders.edu.au.
Publications dans "Substances illicites" :
3 publications dans cette catégorie
Affiliations :
College of Science & Engineering, Flinders University, Adelaide 5042, Australia; Forensic Science SA, GPO Box 2790, Adelaide 5001, Australia.
Publications dans "Substances illicites" :
3 publications dans cette catégorie
Affiliations :
College of Science & Engineering, Flinders University, Adelaide 5042, Australia.
Publications dans "Substances illicites" :
3 publications dans cette catégorie
Affiliations :
Forensic Science SA, GPO Box 2790, Adelaide 5001, Australia.
Publications dans "Substances illicites" :
3 publications dans cette catégorie
Affiliations :
College of Science & Engineering, Flinders University, Adelaide 5042, Australia.
Publications dans "Substances illicites" :
2 publications dans cette catégorie
Publications dans "Substances illicites" :
2 publications dans cette catégorie
Publications dans "Substances illicites" :
2 publications dans cette catégorie
Affiliations :
University of Sao Paulo at Ribeirao Preto College of Nursing, Ribeirao Preto, São Paulo, Brazil. caaventu@eerp.usp.br.
Publications dans "Substances illicites" :
2 publications dans cette catégorie
Affiliations :
University of Sao Paulo at Ribeirao Preto College of Nursing, Ribeirao Preto, São Paulo, Brazil.
Publications dans "Substances illicites" :
2 publications dans cette catégorie
Affiliations :
University of Sao Paulo at Ribeirao Preto College of Nursing, Ribeirao Preto, São Paulo, Brazil.
Publications dans "Substances illicites" :
2 publications dans cette catégorie
Affiliations :
University of Sao Paulo at Ribeirao Preto College of Nursing, Ribeirao Preto, São Paulo, Brazil.
Publications dans "Substances illicites" :
2 publications dans cette catégorie
Affiliations :
University of Sao Paulo at Ribeirao Preto College of Nursing, Ribeirao Preto, São Paulo, Brazil.
Publications dans "Substances illicites" :
2 publications dans cette catégorie
Affiliations :
A-Sense Lab, UAntwerp, Antwerp, Belgium. Karolien.DeWael@uantwerpen.be.
Publications dans "Substances illicites" :
Luminescence-based sensing is capable of being used for the sensitive, rapid, and in some cases selective detection of chemicals. Furthermore, the method is amenable to incorporation into handheld low...
On January 31st, 2023, the province of British Columbia (BC), Canada, was granted a federal exemption allowing adults (aged 18 +) to possess up to 2.5 g of select illicit drugs. The exemption will be ...
The following protocol paper provides a detailed outline of a five-year (2022-2027) national evaluation of BC's decriminalization initiative, as well as the specific objectives, methodologies, and pla...
The overall evaluation and specific sub-study designs were informed by intensive stakeholder engagement. The evaluation was developed in collaboration with an international expert committee who came t...
This evaluation will draw on implementation science research practices to evaluate and understand the full impacts of this novel drug policy experiment. Results will be widely disseminated through man...
Nigeria grapples with a formidable public health concern, as approximately 14 million individuals partake in illicit drug use (IDU). This predicament significantly impacts psychiatric disorders, suici...
Illicit drug use may accelerate coronary disease and cardiac hypertrophy or stimulate arrhythmias. Rates of illicit drug use in young patients with sudden cardiac death (SCD) are uncertain....
The purpose of this study was to identify rates of illicit drug use in young patients with SCD....
A prospective statewide registry identified out-of-hospital patients with cardiac arrest aged 18-50 years from April 2019 to April 2021. Clinical characteristics were compared between patients with an...
A total of 554 (40.2%) of 1378 patients had confirmed cardiac cause of out-of-hospital cardiac arrest, with 523 undergoing toxicological assessment. There were 170 patients (32.5%) having either posit...
Approximately one-third of young patients with SCD have positive toxicology at the time of death or reported frequent use of illicit drugs, with high rates of polysubstance abuse....
In China, over 5 million people have been identified and registered by the public security institutions for using illicit drugs. The aim of this study is to compare the influence of different types of...
The study is based on survey with 6,906 people who use drugs in Guangdong province, China. Risk of mental health issue is measured using the Brief Symptoms Inventory 18 (BSI-18) Scale, and a higher BS...
The three major types of illicit drugs have both moderating and mediating effects on the length of drug-use history, that Heroin use leads to longer drug-use duration, while Ketamine use causes more d...
These three drugs are associated with severe mental health issue in a society with strict drug regulation. Attention should be paid to the mental health of people regardless of the type of drugs they ...
This review aimed to identify current pharmacological and non-pharmacological treatment employed in emergency departments (EDs) for the management of patients presenting with illicit drug-related pres...
The review consists of English peer-reviewed journal articles and grey literature published in electronic databases: Ovid MEDLINE, PubMed, Embase Classic+Embase, Ovid Emcare and APA PsycInfo between 2...
Twelve studies were identified from the search, with agitation and aggression being the most common presentations, and cannabis being the most prevalent illicit drug. Ventilatory support and restraint...
Pharmacological interventions for patients with IDP and related symptoms were in accordance with guidelines. Use of restraints was identified in included studies with notable lack of reporting of de-e...
The detection of human DNA on and within illicit drug preparations is novel and a focus of current research. Previous studies have indicated that certain drug-related powders present in illicit drug p...
Presentations related to illicit drugs are a feature of emergency department practice. Clinicians may form a belief that a patient is intoxicated with illicit drugs based on patient self-report, clini...
A blood sample was taken on patient arrival and details of patient history, examination and interventions were collected by clinical and research staff. Toxicological examination of biological samples...
Of 632 study presentations, 518 had illicit drugs detected representing a positive predictive value of 0.82 (95% confidence interval 78.7, 84.9). Those with illicit drugs detected were significantly l...
In this study, the positive predictive value of clinicians determining if their patient had taken illicit drugs was 0.82. Contemporaneous biochemical analysis in the clinical setting would increase th...
In the Northern Territory (NT) of Australia, there are significant evidence gaps about illicit drug use and harms, despite having established monitoring and reporting systems. This paper reports on il...
Face-to-face and online qualitative interviews were conducted with stakeholders across urban and remote locations in the NT. Key stakeholders were service providers, including acute and primary care c...
Four researchers interviewed 21 participants across urban (62%), and remote areas (38%) of the NT. Themes identified were: (1) Illicit drug use and harms are diverse and distinct; (2) Client support n...
Key stakeholders described illicit drug use, harms and contributing factors, which provided insights into the local challenges. Participants emphasised that clients have complex care needs, and furthe...
The market for illicit drugs and new psychoactive substances (NPS) has grown significantly and people attending festivals have been identified as being at high risk (high extent and frequency of subst...